REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

Share Price Information for Acer Gdr Reg S (ACID)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.55
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 6.55
High: 0.00
Low: 0.00
Prev. Close: 6.55
ACID Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

To announce the Company's information

13 Aug 2021 10:53

RNS Number : 6114I
Acer Incorporated
13 August 2021
 

Subject: Supplemental announcement regarding explanation about the Company's shareholders participating AHCI's capital increase in cash dated Aug. 4th, 2021

Date of events: 2021/08/13

Contents:

1. Date of occurrence of the event: 2021/08/13

2. Company name: Acer Inc.

3. Relationship to the Company (please enter "head office" or "subsidiaries"): head office

4. Reciprocal shareholding ratios: N.A.

5. Cause of occurrence:

For the process of having the shares of Acer Healthcare Inc. ("AHCI") be listed and traded on Taiwan Stock Exchange or Taipei Exchange, the Company decides to release part of the new shares (3,167,675 shares) issued by AHCI's capital increase in cash to the Company's shareholders.

6. Countermeasures:

The item (9) of Statement 7 below is made as supplement to the announcement dated Aug. 4th, 2021

7. Any other matters that need to be specified:

Explanation about the Company's shareholders who are eligible to subscribe the new shares issued by AHCI's capital increase in cash:

(1)The Company's subsidiary, Acer Healthcare Inc. (non-public, hereinafter "AHCI"), will issue 5,000,000 common shares (hereinafter "AHCI new common shares") by second capital increased in cash in 2021. The AHCI new common shares will be issued at NT$16 per share, and it is expected to acquire NT$80 million to enrich capital for AHCI's operation and business. Pursuant to the Article 267 of Company Act, 15% of the AHCI new common shares, i.e. 750,000 common shares, will be reserved for the employees; and the remaining 85% of the AHCI new common shares, i.e. 4,250,000 common shares, will be reserved for the original shareholders of AHCI based on the list of shareholders roster on the dividend record date. Since the Company has held 95.71% of the shares of AHCI, the Company will be able to subscribe 4,067,675 common shares from the AHCI new common shares.

(2)The Company waives subscription from the AHCI new common shares that the Company may subscribed with 3,167,675 shares. The shareholders who are recorded in the Company's shareholders register on the latest book closure date (July 2, 2021) will be qualified to purchase AHCI's common shares with calculating the percentage of whose holding of the Company's common shares, and each share of the Company will be granted to purchase 0.001039 AHCI's common share (will be rounded down to the nearest whole number without any discretion).

(3)Shareholders may apply to the Company's stock affairs office for combination of their shares before the end of the payment date for the transaction. Shareholders not applying for combination within the period or whose combined shares are less than one AHCI's common shares will be deemed to waive whose rights of subscription.

(4)Shareholders who own the Company's share after the book closure date, before the end of the payment date for the purchase, will be granted to apply for the purchase by submitting whose certificate of stock ownership to the Company's stock affairs office. The Company will deem the applicant as the designated individuals and accept whose application of purchase in accordance with the conditions herein.

(5)In accordance with conditions herein, any shareholders who have rights to subscribe more than 1,000 AHCI's common shares, will be provided with the notice of the payment by an ordinary mail.

(6)As to the shareholder whose rights of purchase are less than 1,000 AHCI's common shares, the Company will not provide any notice individually besides this announcement, such shareholders shall contact to the Company's stock affairs office directly.

(7)Planned agenda for the transaction is as follows:

a. The payment term is from August 23, 2021 to August 26, 2021.

b. The end date of the application for the combination of the shares: August 26, 2021.

c. The end date of the application for the shareholders who own the Company's share after the book closure date (July 2, 2021): August 26, 2021.

(8)After the AHCI has been completed its changing registration for capital increase in cash, AHCI will notify the shareholder who participates the subscription separately.

(9)Please refer to the website below for the Company's brief introduction and relevant information:

https://7cf52da4-797d-4e9c-98a9-451cd49b186d.filesusr.com/ugd/765db7_1831529ffb3f405e8afeee1eb698b537.pdf

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKXLBFFVLEBBL
Date   Source Headline
18th Apr 202410:15 amRNSTo announce the Company's information
11th Apr 202410:23 amRNSTo announce the Company's information
10th Apr 202410:16 amRNSUn-Audited Monthly Sales Ended Mar. 31, 2024
2nd Apr 20247:00 amRNSTo Announce the Company's Infomation
14th Mar 202410:01 amRNSTo announce the Company's information
7th Mar 20249:45 amRNSUn-Audited Monthly Sales Ended Feb. 29, 2024
26th Feb 20249:38 amRNSTo announce the Company's information
19th Feb 20249:11 amRNSTo announce the Company's information
7th Feb 20248:03 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2024
17th Jan 202410:05 amRNSTo announce the Company's information
8th Jan 20249:24 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2023
27th Dec 20237:00 amRNSTo announce the Company's information
11th Dec 20239:44 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2023
9th Nov 20239:21 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2023
2nd Nov 20239:15 amRNSTo announce the Company's information
24th Oct 20232:34 pmRNSTo announce the Company's information
16th Oct 20237:24 amRNSTo announce the Company's information
11th Oct 202310:36 amRNSUn-Audited Monthly Sales Ended Sep. 30, 2023
26th Sep 202310:07 amRNSTo announce the Company's information
8th Sep 202310:20 amRNSTo announce the Company's sales and information
5th Sep 20237:10 amRNSTo announce the Company's information
23rd Aug 202310:17 amRNSTo announce the Company's information
9th Aug 202310:13 amRNSUn-Audited Monthly Sales Ended July 31, 2023
8th Aug 202312:16 pmRNSTo announce the Company's information
3rd Aug 20231:09 pmRNSTo announce the Company's information
10th Jul 20237:00 amRNSUn-Audited Monthly Sales Ended June 30, 2023
29th Jun 202310:54 amRNSTo announce the Company's information
8th Jun 202310:17 amRNSUn-Audited Monthly Sales Ended May 31, 2023
7th Jun 20237:00 amRNSTo announce the Company's information
9th May 202310:35 amRNSTo announce the Company's info and Monthly Revenue
4th May 202311:14 amRNSTo announce the Company's information
24th Apr 202310:32 amRNSTo announce the Company's information
11th Apr 202311:05 amRNSTo announce the Company's info and Monthly Revenue
11th Apr 20237:00 amRNSTo announce the Company's information
31st Mar 202310:13 amRNSTo announce the Company's information
16th Mar 202310:24 amRNSTo announce the Company's information
10th Mar 20239:06 amRNSUn-Audited Monthly Sales Ended Feb. 28, 2023
8th Mar 20232:23 pmRNSTo announce the Company's information
2nd Mar 20239:05 amRNSTo announce the Company's information
10th Feb 20239:05 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2023
9th Jan 202310:07 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2022
4th Jan 20239:56 amRNSTo announce the Company's information
16th Dec 20229:12 amRNSTo announce the Company's information
9th Dec 20229:06 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2022
8th Dec 20229:20 amRNSTo announce the Company's information
5th Dec 20229:13 amRNSTo announce the Company's information
29th Nov 202211:14 amRNSTo announce the Company's information
9th Nov 20229:23 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2022
8th Nov 20228:50 amRNSTo announce the Company's information
3rd Nov 202210:04 amRNSTo announce the Company's information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.